nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—forebrain—epilepsy syndrome	0.00378	0.154	CbGeAlD
Ibandronate—FDPS—telencephalon—epilepsy syndrome	0.00347	0.141	CbGeAlD
Ibandronate—FDPS—medulla oblongata—epilepsy syndrome	0.00273	0.111	CbGeAlD
Ibandronate—FDPS—midbrain—epilepsy syndrome	0.0025	0.101	CbGeAlD
Ibandronate—FDPS—spinal cord—epilepsy syndrome	0.00243	0.099	CbGeAlD
Ibandronate—FDPS—head—epilepsy syndrome	0.00216	0.0879	CbGeAlD
Ibandronate—FDPS—nervous system—epilepsy syndrome	0.00205	0.0834	CbGeAlD
Ibandronate—FDPS—central nervous system—epilepsy syndrome	0.00197	0.0803	CbGeAlD
Ibandronate—FDPS—cerebellum—epilepsy syndrome	0.00193	0.0785	CbGeAlD
Ibandronate—FDPS—brain—epilepsy syndrome	0.00157	0.0637	CbGeAlD
Ibandronate—Rash—Fosphenytoin—epilepsy syndrome	0.000245	0.000251	CcSEcCtD
Ibandronate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000245	0.000251	CcSEcCtD
Ibandronate—Haemoglobin—Topiramate—epilepsy syndrome	0.000245	0.000251	CcSEcCtD
Ibandronate—Asthenia—Clonazepam—epilepsy syndrome	0.000244	0.000251	CcSEcCtD
Ibandronate—Back pain—Gabapentin—epilepsy syndrome	0.000244	0.00025	CcSEcCtD
Ibandronate—Headache—Fosphenytoin—epilepsy syndrome	0.000244	0.00025	CcSEcCtD
Ibandronate—Haemorrhage—Topiramate—epilepsy syndrome	0.000244	0.00025	CcSEcCtD
Ibandronate—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000243	0.000249	CcSEcCtD
Ibandronate—Palpitations—Pregabalin—epilepsy syndrome	0.000243	0.000249	CcSEcCtD
Ibandronate—Asthenia—Phenytoin—epilepsy syndrome	0.000243	0.000249	CcSEcCtD
Ibandronate—Nausea—Midazolam—epilepsy syndrome	0.000242	0.000248	CcSEcCtD
Ibandronate—Muscle spasms—Gabapentin—epilepsy syndrome	0.000242	0.000248	CcSEcCtD
Ibandronate—Diarrhoea—Zonisamide—epilepsy syndrome	0.000242	0.000248	CcSEcCtD
Ibandronate—Pharyngitis—Topiramate—epilepsy syndrome	0.000242	0.000248	CcSEcCtD
Ibandronate—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000241	0.000248	CcSEcCtD
Ibandronate—Pruritus—Clonazepam—epilepsy syndrome	0.000241	0.000247	CcSEcCtD
Ibandronate—Vomiting—Vigabatrin—epilepsy syndrome	0.000241	0.000247	CcSEcCtD
Ibandronate—Skin disorder—Valproic Acid—epilepsy syndrome	0.000241	0.000247	CcSEcCtD
Ibandronate—Urinary tract disorder—Topiramate—epilepsy syndrome	0.00024	0.000247	CcSEcCtD
Ibandronate—Oedema peripheral—Topiramate—epilepsy syndrome	0.00024	0.000246	CcSEcCtD
Ibandronate—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.00024	0.000246	CcSEcCtD
Ibandronate—Pruritus—Phenytoin—epilepsy syndrome	0.000239	0.000245	CcSEcCtD
Ibandronate—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000239	0.000245	CcSEcCtD
Ibandronate—Nausea—Levetiracetam—epilepsy syndrome	0.000239	0.000245	CcSEcCtD
Ibandronate—Rash—Vigabatrin—epilepsy syndrome	0.000239	0.000245	CcSEcCtD
Ibandronate—Dizziness—Felbamate—epilepsy syndrome	0.000239	0.000245	CcSEcCtD
Ibandronate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000239	0.000245	CcSEcCtD
Ibandronate—Urethral disorder—Topiramate—epilepsy syndrome	0.000239	0.000245	CcSEcCtD
Ibandronate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000238	0.000244	CcSEcCtD
Ibandronate—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000238	0.000244	CcSEcCtD
Ibandronate—Headache—Vigabatrin—epilepsy syndrome	0.000237	0.000243	CcSEcCtD
Ibandronate—Hypertension—Pregabalin—epilepsy syndrome	0.000237	0.000243	CcSEcCtD
Ibandronate—Vomiting—Diazepam—epilepsy syndrome	0.000237	0.000243	CcSEcCtD
Ibandronate—Rash—Diazepam—epilepsy syndrome	0.000235	0.000241	CcSEcCtD
Ibandronate—Dermatitis—Diazepam—epilepsy syndrome	0.000235	0.000241	CcSEcCtD
Ibandronate—Arthralgia—Pregabalin—epilepsy syndrome	0.000234	0.00024	CcSEcCtD
Ibandronate—Chest pain—Pregabalin—epilepsy syndrome	0.000234	0.00024	CcSEcCtD
Ibandronate—Myalgia—Pregabalin—epilepsy syndrome	0.000234	0.00024	CcSEcCtD
Ibandronate—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000234	0.00024	CcSEcCtD
Ibandronate—Dizziness—Zonisamide—epilepsy syndrome	0.000234	0.00024	CcSEcCtD
Ibandronate—Headache—Diazepam—epilepsy syndrome	0.000234	0.00024	CcSEcCtD
Ibandronate—Anxiety—Pregabalin—epilepsy syndrome	0.000233	0.000239	CcSEcCtD
Ibandronate—Diarrhoea—Clonazepam—epilepsy syndrome	0.000233	0.000239	CcSEcCtD
Ibandronate—Anaemia—Gabapentin—epilepsy syndrome	0.000233	0.000239	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000232	0.000238	CcSEcCtD
Ibandronate—Asthenia—Carbamazepine—epilepsy syndrome	0.000232	0.000238	CcSEcCtD
Ibandronate—Diarrhoea—Phenytoin—epilepsy syndrome	0.000232	0.000237	CcSEcCtD
Ibandronate—Discomfort—Pregabalin—epilepsy syndrome	0.000231	0.000237	CcSEcCtD
Ibandronate—Nausea—Fosphenytoin—epilepsy syndrome	0.000231	0.000237	CcSEcCtD
Ibandronate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.00023	0.000236	CcSEcCtD
Ibandronate—Angioedema—Gabapentin—epilepsy syndrome	0.00023	0.000236	CcSEcCtD
Ibandronate—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.00023	0.000236	CcSEcCtD
Ibandronate—Vomiting—Felbamate—epilepsy syndrome	0.00023	0.000235	CcSEcCtD
Ibandronate—Dry mouth—Pregabalin—epilepsy syndrome	0.000229	0.000235	CcSEcCtD
Ibandronate—Pruritus—Carbamazepine—epilepsy syndrome	0.000229	0.000234	CcSEcCtD
Ibandronate—Rash—Felbamate—epilepsy syndrome	0.000228	0.000233	CcSEcCtD
Ibandronate—Eye disorder—Topiramate—epilepsy syndrome	0.000228	0.000233	CcSEcCtD
Ibandronate—Dermatitis—Felbamate—epilepsy syndrome	0.000227	0.000233	CcSEcCtD
Ibandronate—Malaise—Gabapentin—epilepsy syndrome	0.000227	0.000233	CcSEcCtD
Ibandronate—Vertigo—Gabapentin—epilepsy syndrome	0.000226	0.000232	CcSEcCtD
Ibandronate—Headache—Felbamate—epilepsy syndrome	0.000226	0.000232	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000226	0.000232	CcSEcCtD
Ibandronate—Cardiac disorder—Topiramate—epilepsy syndrome	0.000226	0.000232	CcSEcCtD
Ibandronate—Dizziness—Clonazepam—epilepsy syndrome	0.000225	0.000231	CcSEcCtD
Ibandronate—Nausea—Vigabatrin—epilepsy syndrome	0.000225	0.000231	CcSEcCtD
Ibandronate—Vomiting—Zonisamide—epilepsy syndrome	0.000225	0.00023	CcSEcCtD
Ibandronate—Insomnia—Valproic Acid—epilepsy syndrome	0.000224	0.00023	CcSEcCtD
Ibandronate—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000224	0.00023	CcSEcCtD
Ibandronate—Asthenia—Lamotrigine—epilepsy syndrome	0.000224	0.00023	CcSEcCtD
Ibandronate—Dizziness—Phenytoin—epilepsy syndrome	0.000224	0.000229	CcSEcCtD
Ibandronate—Rash—Zonisamide—epilepsy syndrome	0.000223	0.000228	CcSEcCtD
Ibandronate—Infection—Pregabalin—epilepsy syndrome	0.000223	0.000228	CcSEcCtD
Ibandronate—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000223	0.000228	CcSEcCtD
Ibandronate—Palpitations—Gabapentin—epilepsy syndrome	0.000223	0.000228	CcSEcCtD
Ibandronate—Dermatitis—Zonisamide—epilepsy syndrome	0.000223	0.000228	CcSEcCtD
Ibandronate—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000223	0.000228	CcSEcCtD
Ibandronate—Nausea—Diazepam—epilepsy syndrome	0.000222	0.000227	CcSEcCtD
Ibandronate—Headache—Zonisamide—epilepsy syndrome	0.000221	0.000227	CcSEcCtD
Ibandronate—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000221	0.000227	CcSEcCtD
Ibandronate—Angiopathy—Topiramate—epilepsy syndrome	0.000221	0.000227	CcSEcCtD
Ibandronate—Pruritus—Lamotrigine—epilepsy syndrome	0.000221	0.000226	CcSEcCtD
Ibandronate—Shock—Pregabalin—epilepsy syndrome	0.000221	0.000226	CcSEcCtD
Ibandronate—Immune system disorder—Topiramate—epilepsy syndrome	0.00022	0.000226	CcSEcCtD
Ibandronate—Nervous system disorder—Pregabalin—epilepsy syndrome	0.00022	0.000225	CcSEcCtD
Ibandronate—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000219	0.000225	CcSEcCtD
Ibandronate—Chills—Topiramate—epilepsy syndrome	0.000218	0.000224	CcSEcCtD
Ibandronate—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000218	0.000224	CcSEcCtD
Ibandronate—Skin disorder—Pregabalin—epilepsy syndrome	0.000218	0.000223	CcSEcCtD
Ibandronate—Hypertension—Gabapentin—epilepsy syndrome	0.000218	0.000223	CcSEcCtD
Ibandronate—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000217	0.000222	CcSEcCtD
Ibandronate—Vomiting—Clonazepam—epilepsy syndrome	0.000217	0.000222	CcSEcCtD
Ibandronate—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000216	0.000221	CcSEcCtD
Ibandronate—Alopecia—Topiramate—epilepsy syndrome	0.000215	0.000221	CcSEcCtD
Ibandronate—Vomiting—Phenytoin—epilepsy syndrome	0.000215	0.000221	CcSEcCtD
Ibandronate—Rash—Clonazepam—epilepsy syndrome	0.000215	0.00022	CcSEcCtD
Ibandronate—Dermatitis—Clonazepam—epilepsy syndrome	0.000215	0.00022	CcSEcCtD
Ibandronate—Chest pain—Gabapentin—epilepsy syndrome	0.000215	0.00022	CcSEcCtD
Ibandronate—Arthralgia—Gabapentin—epilepsy syndrome	0.000215	0.00022	CcSEcCtD
Ibandronate—Myalgia—Gabapentin—epilepsy syndrome	0.000215	0.00022	CcSEcCtD
Ibandronate—Nausea—Felbamate—epilepsy syndrome	0.000214	0.00022	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000214	0.00022	CcSEcCtD
Ibandronate—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000214	0.000219	CcSEcCtD
Ibandronate—Fatigue—Valproic Acid—epilepsy syndrome	0.000214	0.000219	CcSEcCtD
Ibandronate—Anxiety—Gabapentin—epilepsy syndrome	0.000214	0.000219	CcSEcCtD
Ibandronate—Dizziness—Carbamazepine—epilepsy syndrome	0.000214	0.000219	CcSEcCtD
Ibandronate—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000214	0.000219	CcSEcCtD
Ibandronate—Headache—Clonazepam—epilepsy syndrome	0.000213	0.000219	CcSEcCtD
Ibandronate—Rash—Phenytoin—epilepsy syndrome	0.000213	0.000219	CcSEcCtD
Ibandronate—Mental disorder—Topiramate—epilepsy syndrome	0.000213	0.000219	CcSEcCtD
Ibandronate—Dermatitis—Phenytoin—epilepsy syndrome	0.000213	0.000219	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000213	0.000218	CcSEcCtD
Ibandronate—Rash—Oxcarbazepine—epilepsy syndrome	0.000212	0.000218	CcSEcCtD
Ibandronate—Pain—Valproic Acid—epilepsy syndrome	0.000212	0.000217	CcSEcCtD
Ibandronate—Constipation—Valproic Acid—epilepsy syndrome	0.000212	0.000217	CcSEcCtD
Ibandronate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000212	0.000217	CcSEcCtD
Ibandronate—Headache—Phenytoin—epilepsy syndrome	0.000212	0.000217	CcSEcCtD
Ibandronate—Erythema—Topiramate—epilepsy syndrome	0.000212	0.000217	CcSEcCtD
Ibandronate—Malnutrition—Topiramate—epilepsy syndrome	0.000212	0.000217	CcSEcCtD
Ibandronate—Discomfort—Gabapentin—epilepsy syndrome	0.000212	0.000217	CcSEcCtD
Ibandronate—Headache—Oxcarbazepine—epilepsy syndrome	0.000211	0.000216	CcSEcCtD
Ibandronate—Nausea—Zonisamide—epilepsy syndrome	0.00021	0.000215	CcSEcCtD
Ibandronate—Dry mouth—Gabapentin—epilepsy syndrome	0.00021	0.000215	CcSEcCtD
Ibandronate—Flatulence—Topiramate—epilepsy syndrome	0.000209	0.000214	CcSEcCtD
Ibandronate—Dysgeusia—Topiramate—epilepsy syndrome	0.000208	0.000213	CcSEcCtD
Ibandronate—Dizziness—Lamotrigine—epilepsy syndrome	0.000206	0.000212	CcSEcCtD
Ibandronate—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000206	0.000211	CcSEcCtD
Ibandronate—Vomiting—Carbamazepine—epilepsy syndrome	0.000205	0.000211	CcSEcCtD
Ibandronate—Back pain—Topiramate—epilepsy syndrome	0.000205	0.00021	CcSEcCtD
Ibandronate—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000204	0.00021	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000204	0.000209	CcSEcCtD
Ibandronate—Infection—Gabapentin—epilepsy syndrome	0.000204	0.000209	CcSEcCtD
Ibandronate—Muscle spasms—Topiramate—epilepsy syndrome	0.000204	0.000209	CcSEcCtD
Ibandronate—Rash—Carbamazepine—epilepsy syndrome	0.000204	0.000209	CcSEcCtD
Ibandronate—Dermatitis—Carbamazepine—epilepsy syndrome	0.000203	0.000209	CcSEcCtD
Ibandronate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000203	0.000208	CcSEcCtD
Ibandronate—Insomnia—Pregabalin—epilepsy syndrome	0.000203	0.000208	CcSEcCtD
Ibandronate—Nausea—Clonazepam—epilepsy syndrome	0.000202	0.000207	CcSEcCtD
Ibandronate—Headache—Carbamazepine—epilepsy syndrome	0.000202	0.000207	CcSEcCtD
Ibandronate—Shock—Gabapentin—epilepsy syndrome	0.000202	0.000207	CcSEcCtD
Ibandronate—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000202	0.000207	CcSEcCtD
Ibandronate—Paraesthesia—Pregabalin—epilepsy syndrome	0.000201	0.000206	CcSEcCtD
Ibandronate—Nausea—Phenytoin—epilepsy syndrome	0.000201	0.000206	CcSEcCtD
Ibandronate—Nausea—Oxcarbazepine—epilepsy syndrome	0.0002	0.000205	CcSEcCtD
Ibandronate—Skin disorder—Gabapentin—epilepsy syndrome	0.0002	0.000205	CcSEcCtD
Ibandronate—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000199	0.000204	CcSEcCtD
Ibandronate—Vomiting—Lamotrigine—epilepsy syndrome	0.000198	0.000203	CcSEcCtD
Ibandronate—Urticaria—Valproic Acid—epilepsy syndrome	0.000197	0.000202	CcSEcCtD
Ibandronate—Rash—Lamotrigine—epilepsy syndrome	0.000197	0.000202	CcSEcCtD
Ibandronate—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000197	0.000202	CcSEcCtD
Ibandronate—Dermatitis—Lamotrigine—epilepsy syndrome	0.000197	0.000202	CcSEcCtD
Ibandronate—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000196	0.000201	CcSEcCtD
Ibandronate—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000196	0.000201	CcSEcCtD
Ibandronate—Anaemia—Topiramate—epilepsy syndrome	0.000196	0.000201	CcSEcCtD
Ibandronate—Headache—Lamotrigine—epilepsy syndrome	0.000196	0.0002	CcSEcCtD
Ibandronate—Decreased appetite—Pregabalin—epilepsy syndrome	0.000195	0.0002	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000194	0.000198	CcSEcCtD
Ibandronate—Fatigue—Pregabalin—epilepsy syndrome	0.000193	0.000198	CcSEcCtD
Ibandronate—Nausea—Carbamazepine—epilepsy syndrome	0.000192	0.000197	CcSEcCtD
Ibandronate—Pain—Pregabalin—epilepsy syndrome	0.000192	0.000197	CcSEcCtD
Ibandronate—Constipation—Pregabalin—epilepsy syndrome	0.000192	0.000197	CcSEcCtD
Ibandronate—Malaise—Topiramate—epilepsy syndrome	0.000191	0.000196	CcSEcCtD
Ibandronate—Vertigo—Topiramate—epilepsy syndrome	0.00019	0.000195	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000187	0.000192	CcSEcCtD
Ibandronate—Palpitations—Topiramate—epilepsy syndrome	0.000187	0.000192	CcSEcCtD
Ibandronate—Insomnia—Gabapentin—epilepsy syndrome	0.000186	0.000191	CcSEcCtD
Ibandronate—Nausea—Lamotrigine—epilepsy syndrome	0.000185	0.00019	CcSEcCtD
Ibandronate—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000185	0.000189	CcSEcCtD
Ibandronate—Paraesthesia—Gabapentin—epilepsy syndrome	0.000185	0.000189	CcSEcCtD
Ibandronate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000183	0.000188	CcSEcCtD
Ibandronate—Hypertension—Topiramate—epilepsy syndrome	0.000183	0.000188	CcSEcCtD
Ibandronate—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000183	0.000187	CcSEcCtD
Ibandronate—Dyspepsia—Gabapentin—epilepsy syndrome	0.000181	0.000186	CcSEcCtD
Ibandronate—Arthralgia—Topiramate—epilepsy syndrome	0.00018	0.000185	CcSEcCtD
Ibandronate—Chest pain—Topiramate—epilepsy syndrome	0.00018	0.000185	CcSEcCtD
Ibandronate—Myalgia—Topiramate—epilepsy syndrome	0.00018	0.000185	CcSEcCtD
Ibandronate—Anxiety—Topiramate—epilepsy syndrome	0.00018	0.000184	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000179	0.000184	CcSEcCtD
Ibandronate—Decreased appetite—Gabapentin—epilepsy syndrome	0.000179	0.000183	CcSEcCtD
Ibandronate—Discomfort—Topiramate—epilepsy syndrome	0.000178	0.000183	CcSEcCtD
Ibandronate—Urticaria—Pregabalin—epilepsy syndrome	0.000178	0.000183	CcSEcCtD
Ibandronate—Asthenia—Valproic Acid—epilepsy syndrome	0.000178	0.000182	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000178	0.000182	CcSEcCtD
Ibandronate—Fatigue—Gabapentin—epilepsy syndrome	0.000177	0.000182	CcSEcCtD
Ibandronate—Body temperature increased—Pregabalin—epilepsy syndrome	0.000177	0.000182	CcSEcCtD
Ibandronate—Abdominal pain—Pregabalin—epilepsy syndrome	0.000177	0.000182	CcSEcCtD
Ibandronate—Dry mouth—Topiramate—epilepsy syndrome	0.000177	0.000181	CcSEcCtD
Ibandronate—Pain—Gabapentin—epilepsy syndrome	0.000176	0.00018	CcSEcCtD
Ibandronate—Constipation—Gabapentin—epilepsy syndrome	0.000176	0.00018	CcSEcCtD
Ibandronate—Pruritus—Valproic Acid—epilepsy syndrome	0.000176	0.00018	CcSEcCtD
Ibandronate—Infection—Topiramate—epilepsy syndrome	0.000172	0.000176	CcSEcCtD
Ibandronate—Shock—Topiramate—epilepsy syndrome	0.00017	0.000175	CcSEcCtD
Ibandronate—Diarrhoea—Valproic Acid—epilepsy syndrome	0.00017	0.000174	CcSEcCtD
Ibandronate—Nervous system disorder—Topiramate—epilepsy syndrome	0.00017	0.000174	CcSEcCtD
Ibandronate—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000169	0.000174	CcSEcCtD
Ibandronate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000168	0.000172	CcSEcCtD
Ibandronate—Skin disorder—Topiramate—epilepsy syndrome	0.000168	0.000172	CcSEcCtD
Ibandronate—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000167	0.000171	CcSEcCtD
Ibandronate—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000165	0.000169	CcSEcCtD
Ibandronate—Dizziness—Valproic Acid—epilepsy syndrome	0.000164	0.000168	CcSEcCtD
Ibandronate—Urticaria—Gabapentin—epilepsy syndrome	0.000163	0.000167	CcSEcCtD
Ibandronate—Body temperature increased—Gabapentin—epilepsy syndrome	0.000163	0.000167	CcSEcCtD
Ibandronate—Abdominal pain—Gabapentin—epilepsy syndrome	0.000163	0.000167	CcSEcCtD
Ibandronate—Asthenia—Pregabalin—epilepsy syndrome	0.000161	0.000165	CcSEcCtD
Ibandronate—Pruritus—Pregabalin—epilepsy syndrome	0.000159	0.000163	CcSEcCtD
Ibandronate—Vomiting—Valproic Acid—epilepsy syndrome	0.000158	0.000162	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000158	0.000162	CcSEcCtD
Ibandronate—Insomnia—Topiramate—epilepsy syndrome	0.000156	0.00016	CcSEcCtD
Ibandronate—Rash—Valproic Acid—epilepsy syndrome	0.000156	0.00016	CcSEcCtD
Ibandronate—Dermatitis—Valproic Acid—epilepsy syndrome	0.000156	0.00016	CcSEcCtD
Ibandronate—Headache—Valproic Acid—epilepsy syndrome	0.000155	0.000159	CcSEcCtD
Ibandronate—Paraesthesia—Topiramate—epilepsy syndrome	0.000155	0.000159	CcSEcCtD
Ibandronate—Diarrhoea—Pregabalin—epilepsy syndrome	0.000153	0.000157	CcSEcCtD
Ibandronate—Dyspepsia—Topiramate—epilepsy syndrome	0.000152	0.000156	CcSEcCtD
Ibandronate—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000152	0.000155	CcSEcCtD
Ibandronate—Decreased appetite—Topiramate—epilepsy syndrome	0.00015	0.000154	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000149	0.000153	CcSEcCtD
Ibandronate—Fatigue—Topiramate—epilepsy syndrome	0.000149	0.000153	CcSEcCtD
Ibandronate—Dizziness—Pregabalin—epilepsy syndrome	0.000148	0.000152	CcSEcCtD
Ibandronate—Pain—Topiramate—epilepsy syndrome	0.000148	0.000152	CcSEcCtD
Ibandronate—Constipation—Topiramate—epilepsy syndrome	0.000148	0.000152	CcSEcCtD
Ibandronate—Asthenia—Gabapentin—epilepsy syndrome	0.000148	0.000151	CcSEcCtD
Ibandronate—Nausea—Valproic Acid—epilepsy syndrome	0.000147	0.000151	CcSEcCtD
Ibandronate—Pruritus—Gabapentin—epilepsy syndrome	0.000145	0.000149	CcSEcCtD
Ibandronate—Vomiting—Pregabalin—epilepsy syndrome	0.000143	0.000146	CcSEcCtD
Ibandronate—Feeling abnormal—Topiramate—epilepsy syndrome	0.000143	0.000146	CcSEcCtD
Ibandronate—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000141	0.000145	CcSEcCtD
Ibandronate—Rash—Pregabalin—epilepsy syndrome	0.000141	0.000145	CcSEcCtD
Ibandronate—Dermatitis—Pregabalin—epilepsy syndrome	0.000141	0.000145	CcSEcCtD
Ibandronate—Diarrhoea—Gabapentin—epilepsy syndrome	0.000141	0.000144	CcSEcCtD
Ibandronate—Headache—Pregabalin—epilepsy syndrome	0.00014	0.000144	CcSEcCtD
Ibandronate—Urticaria—Topiramate—epilepsy syndrome	0.000137	0.000141	CcSEcCtD
Ibandronate—Body temperature increased—Topiramate—epilepsy syndrome	0.000137	0.00014	CcSEcCtD
Ibandronate—Abdominal pain—Topiramate—epilepsy syndrome	0.000137	0.00014	CcSEcCtD
Ibandronate—Dizziness—Gabapentin—epilepsy syndrome	0.000136	0.000139	CcSEcCtD
Ibandronate—Nausea—Pregabalin—epilepsy syndrome	0.000133	0.000137	CcSEcCtD
Ibandronate—Vomiting—Gabapentin—epilepsy syndrome	0.000131	0.000134	CcSEcCtD
Ibandronate—Rash—Gabapentin—epilepsy syndrome	0.00013	0.000133	CcSEcCtD
Ibandronate—Dermatitis—Gabapentin—epilepsy syndrome	0.00013	0.000133	CcSEcCtD
Ibandronate—Headache—Gabapentin—epilepsy syndrome	0.000129	0.000132	CcSEcCtD
Ibandronate—Hypersensitivity—Topiramate—epilepsy syndrome	0.000127	0.000131	CcSEcCtD
Ibandronate—Asthenia—Topiramate—epilepsy syndrome	0.000124	0.000127	CcSEcCtD
Ibandronate—Pruritus—Topiramate—epilepsy syndrome	0.000122	0.000125	CcSEcCtD
Ibandronate—Nausea—Gabapentin—epilepsy syndrome	0.000122	0.000125	CcSEcCtD
Ibandronate—Diarrhoea—Topiramate—epilepsy syndrome	0.000118	0.000121	CcSEcCtD
Ibandronate—Dizziness—Topiramate—epilepsy syndrome	0.000114	0.000117	CcSEcCtD
Ibandronate—Vomiting—Topiramate—epilepsy syndrome	0.00011	0.000113	CcSEcCtD
Ibandronate—Rash—Topiramate—epilepsy syndrome	0.000109	0.000112	CcSEcCtD
Ibandronate—Dermatitis—Topiramate—epilepsy syndrome	0.000109	0.000112	CcSEcCtD
Ibandronate—Headache—Topiramate—epilepsy syndrome	0.000108	0.000111	CcSEcCtD
Ibandronate—Nausea—Topiramate—epilepsy syndrome	0.000103	0.000105	CcSEcCtD
